Recombinant Human IL25 Protein, MYC/DDK-tagged
|Product Overview :||Recombinant human IL25 protein, fused to MYC/DDK-tagged at C-terminus, was expressed in HEK293|
- Gene Information
- Related Products
|Description :||The protein encoded by this gene is a cytokine that shares sequence similarity with interleukin 17. This cytokine can induce NF-kappaB activation, and stimulate the production of interleukin 8. Both this cytokine and interleukin 17B are ligands for the cytokine receptor IL17BR. Studies of a similar gene in mice suggest that this cytokine may be a pro-inflammatory cytokine favoring the Th2-type immune response. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2010].|
|Form :||25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10% glycerol.|
|Molecular Mass :||16.7 kDa|
|Purity :||> 80% as determined by SDS-PAGE and Coomassie blue staining|
|Concentration :||>50 ug/mL as determined by microplate BCA method|
|Gene Name :||IL25 interleukin 25 [ Homo sapiens ]|
|Official Symbol :||IL25|
|Synonyms :||IL17E; IL17E|
|Gene ID :||64806|
|mRNA Refseq :||NM_022789|
|Protein Refseq :||NP_073626|
|UniProt ID :||Q9H293|
|◆ Recombinant Protein|
|Il25-23M||Active Recombinant Mouse Il25 Protein (Val17-Ala169), C-His tagged, Animal-free, Carrier-free||+Inquiry|
|IL25-5209R||Active Recombinant Rat IL25 Protein||+Inquiry|
|Il25-1011M||Recombinant Mouse Il25 Protein, MYC/DDK-tagged||+Inquiry|
|IL25-182H||Recombinant Active Human IL25 Protein, His-tagged(C-ter)||+Inquiry|
|Il25-183M||Recombinant Active Mouse IL25 Protein, His-tagged(C-ter)||+Inquiry|
|IL25-1261RCL||Recombinant Rat IL25 cell lysate||+Inquiry|
|IL25-2910MCL||Recombinant Mouse IL25 cell lysate||+Inquiry|
|IL25-2920HCL||Recombinant Human IL25 cell lysate||+Inquiry|
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Q&As (6)Ask a question
There is a lack of conclusive evidence that IL-25 has a clear effect in tumor treatment, but there are some studies underway.
There are no clear studies on the side effects of IL-25, but the patient response needs to be closely monitored during research and clinical application.
In addition to treating asthma and inflammatory bowel disease, IL-25 may also have potential applications in the treatment of lung infections, urticaria and other diseases.
IL-25 activates specific signaling pathways by binding to specific receptors, thereby regulating the activity of immune cells and the degree of inflammation in the body.
Some studies have shown that recombinant IL-25 can improve symptoms of diseases such as asthma and inflammatory bowel disease, but more research is needed to verify its efficacy.
Yes, in general, IL-25 therapy needs to be administered by injection to ensure that the protein can enter the body and work.
Customer Reviews (3)Write a review
Efficacy of the protein can be evaluated by observing its pharmacokinetics, pharmacodynamics and toxicity in mice or rats. -
Animal models were used to evaluate the efficacy and side effects of the remade proteins. -
Storage is stable, and the environmental requirements are not harsh. -
Ask a Question for All IL25 Products
Required fields are marked with *
My Review for All IL25 Products
Required fields are marked with *